Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Equity (2016 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Return on Equity for 15 consecutive years, with 1.08% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 79.0% year-over-year to 1.08%, compared with a TTM value of 1.08% through Sep 2025, up 79.0%, and an annual FY2024 reading of 0.05%, down 221.0% over the prior year.
  • Return on Equity was 1.08% for Q3 2025 at Fennec Pharmaceuticals, down from 1.73% in the prior quarter.
  • Across five years, Return on Equity topped out at 3.63% in Q2 2024 and bottomed at 133.04% in Q4 2022.
  • Average Return on Equity over 5 years is 6.82%, with a median of 0.13% recorded in 2024.
  • The sharpest move saw Return on Equity surged 13446bps in 2023, then tumbled -434bps in 2024.
  • Year by year, Return on Equity stood at 0.79% in 2021, then tumbled by -16783bps to 133.04% in 2022, then skyrocketed by 101bps to 1.42% in 2023, then tumbled by -102bps to 0.03% in 2024, then surged by 3388bps to 1.08% in 2025.
  • Business Quant data shows Return on Equity for FENC at 1.08% in Q3 2025, 1.73% in Q2 2025, and 2.36% in Q1 2025.